Skip to main content
Caplight Logo









PreMed.PK

PreMed.PK

Private
KarachiConsumer & Commercehttps://premed.pk

Last Round

Accelerator

Jun 23, 2023

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PreMed.PK operates in Consumer & Commerce and is based in Karachi. Its latest recorded funding round was an Accelerator round in June 2023.

PreMed.PK is an EdTech company that provides a digital study preparation platform for medical entrance exams in Pakistan.

Sector

Consumer & Commerce

Verticals

D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PreMed.PK Comparables

Compare PreMed.PK with similar companies based on industry and business-model similarity.

PreMed.PK comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chaajao
92%
TopGrade.pk
92%
Maqsad
88%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PreMed.PK Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 23, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

PreMed.PK Investors

Notable investors and investment history

PreMed.PK investors
InvestorRounds
National Incubation Center KarachiAccelerator
i2i VenturesAccelerator
Founder InstituteAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 32% MoM.

  • Jun 18, 2026

    Monthly visitors increased 58% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

PreMed.PK Filings

Explore SEC and related filing metadata, where available.

PreMed.PK filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PreMed.PK's valuation, stock price, and market status.

Is PreMed.PK a public or private company?

PreMed.PK is a private company.

What is the current stock price of PreMed.PK?

PreMed.PK is a private company, so its shares have no public market price. Caplight tracks PreMed.PK's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PreMed.PK worth (valuation)?

Valuation information for PreMed.PK is not publicly available.

Can I buy PreMed.PK stock?

PreMed.PK shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PreMed.PK's last funding round?

PreMed.PK's most recent funding round was Accelerator on June 23, 2023.

Who are the main investors in PreMed.PK?

Key investors in PreMed.PK include National Incubation Center Karachi, i2i Ventures, Founder Institute.

Will PreMed.PK IPO soon?

No public IPO plans have been announced for PreMed.PK.

How can I track PreMed.PK secondary market activity?

Caplight tracks bids, offers, and trades in PreMed.PK's shares on secondary markets.

Firmographic Details

HeadquartersKarachi
Employee Range111
Year Founded2020
Last FundingJun 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?